Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes by Wang, Lei et al.
© 2011 Wang et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2011:6 2641–2652
International Journal of Nanomedicine
Synergistic enhancement of cancer therapy using 
a combination of docetaxel and photothermal 
ablation induced by single-walled carbon nanotubes
Lei Wang1
Mingyue Zhang1
Nan Zhang1
Jinjin Shi1
Hongling Zhang1
Min Li1
Chao Lu2
Zhenzhong Zhang1
1School of Pharmaceutical Sciences, 
Zhengzhou University, Zhengzhou, 
People’s Republic of China; 2University 
of Maryland, College Park, MD, USA
Correspondence: Zhenzhong Zhang 
School of Pharmaceutical Sciences, 
Zhengzhou University, Zhengzhou, 
100 Kexue Avenue, 450000,  
People’s Republic of China 
Tel +86 371 6778 1910 
Fax +86 371 6778 1908 
Email zhangzz08@126.com
Background: Single-walled carbon nanotubes (SWNT) are poorly soluble in water, so their 
applications are limited. Therefore, aqueous solutions of SWNT, designed by noncovalent 
functionalization and without toxicity, are required for biomedical applications.
Methods: In this study, we conjugated docetaxel with SWNT via π-π accumulation and used 
a surfactant to functionalize SWNT noncovalently. The SWNT were then conjugated with 
docetaxel (DTX-SWNT) and linked with NGR (Asn-Gly-Arg) peptide, which targets tumor 
angiogenesis, to obtain a water-soluble and tumor-targeting SWNT-NGR-DTX drug delivery 
system.
Results: SWNT-NGR-DTX showed higher efficacy than docetaxel in suppressing tumor 
growth in a cultured PC3 cell line in vitro and in a murine S180 cancer model. Tumor volumes 
in the S180 mouse model decreased considerably under near-infrared radiation compared with 
the control group.
Conclusion: The SWNT-NGR-DTX drug delivery system may be promising for high treatment 
efficacy with minimal side effects in future cancer therapy.
Keywords: single-walled carbon nanotubes, docetaxel, NGR peptide, tumor-targeting, 
  near-infrared radiation
Introduction
Due to the unique physical and chemical properties of carbon nanotubes, they are con-
sidered to be potential biomedical materials for delivery of biological macromolecules 
and chemicals into cells and living systems for the purposes of disease diagnosis and 
therapy.1–3 According to the size of single-walled nanotubes (SWNT) and their uptake 
by cells, targeted delivery of SWNT-borne pharmaceuticals at the cellular level could 
be enhanced, and the discomfort associated with current intrusive techniques could be 
minimized. SWNT is a unique one-dimensional material, and has been explored as a 
novel drug delivery vehicle in vitro.4,5 SWNT can effectively shuttle various biomol-
ecules including drugs, peptides, proteins, plasmid DNA, and small interfering RNA 
into cells via endocytosis.6–9 SWNT are not soluble in aqueous solution, which limits 
their application. However, SWNT with particular design features are able to enter 
cells without toxicity, giving this nanomaterial wide biomedical applications.10–12
Angiogenic tumor vessels are important elements for tumor growth and   metastasis. 
They are essential for transporting metabolically essential materials to and from tumor 
cells, and also provide a route for dissemination of tumor cells to distal sites. The 
Asn-Gly-Arg (NGR) peptide motif has been used as a targeting head for   target drugs 
and drug-containing liposomes to CD13, the tumor vascular antigen,13,14   resulting 
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in improved biodistribution and more effective tumor 
therapy.15,16 Peptides containing NGR have shown high 
efficiency in targeted cells and tissues.17,18
Docetaxel (N-debenzoyl-N-tert-butoxy-carbonyl-10-
deacetyl) is a new class of taxane, which has achieved higher 
patient response rates and fewer side effects compared with 
paclitaxel in the treatment of a wide spectrum of cancers, 
including breast, ovarian, small and nonsmall cell lung, 
and head/neck cancer.19–22 Both paclitaxel and docetaxel 
act by binding to microtubules and inhibiting microtubule 
depolymerization to free tubulin. As a result, the equilibrium 
within the microtubule system is disrupted, leading to mitotic 
arrest in the G2/M phase of the cell cycle and ultimately to 
cell death.23 In this study, docetaxel was used as a model 
anticancer agent.
Biological systems are known to be highly transparent 
under 700–1100 nm near-infrared light. The strong opti-
cal absorbance of SWNT can be used for photothermal 
therapy to afford multifunctional biological nanotube 
transporters.24–28 Continuous near-infrared irradiation can 
cause cell death in vitro because of excessive local heating 
of the SWNT.29
In this study, we developed a SWNT-NGR delivery 
system conjugated with docetaxel (SWNT-NGR-DTX). 
In this delivery system, docetaxel was attached through 
π-π accumulation to SWNT and dispersed in water with 
PVPk30 and 1,2-distearoyl-sn-glycero-3-phosphoetha-
nolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-
PEG2000)-maleimide (DPM). Because the maleimide group 
at the end of DPM on the surface of SWNT can react with 
the double bond in the sulfhydryl groups, the maleimide was 
reacted with cysteine in CNGRCK2HK3HK11 (C containing 
sulfhydryl groups) and connected covalently. This delivery 
system targeted as tumor cells as shown in Figure 1. It was 
hypothesized that the docetaxel attached to SWNT would 
be released from the SWNT-NGR-DTX delivery system in 
a sustained fashion, and the ability of docetaxel to kill tumor 
cells would be enhanced through near-infrared irradiation-
mediated tumor destruction by the photothermal effect on 
the carbon nanotubes.
Materials and methods
SWNT produced by chemical vapor deposition (purity . 90%) 
were purchased from Chengdu Organic Chemicals Co Ltd 
(Chengdu, China). A PC3 human prostate cancer cell line 
and S180 mouse ascites tumor cells were obtained from the 
Chinese Academy of Sciences Cell Bank. NGR peptides 
(CNGRCK2HK3HK11) were compounded by Shanghai 
Figure 1 Docetaxel delivery system using noncovalent functionalization of carbon nanotubes. 
Abbreviations: DSPE-PEg, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]; NgR, (Asn-gly-Arg) peptide; DTX, docetaxel.
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Botai Biotechnology Co Ltd (Shanghai, China). Docetaxel 
was purchased from Beijing YiHe Biotechnology Co Ltd, 
DPM and other reagents were all purchased from Sigma 
(St Louis, MO). Experimental animals were provided by the 
Henan Laboratory Animal Center.
Preparation of SWNT-DTX
SWNT 5 mg was mixed with docetaxel 20 mg in anhydrous 
ethanol 0.5 mL using an ultrasonic bath for about 15 minutes 
while dropwise phosphate-buffered solution 3 mL was added. 
The mixture was ultrasonicated using an ultrasonic probe 
(400 W, 10 times). The suspension was centrifuged at 10,000 
rpm for 15 minutes until the SWNT were fully precipitated, 
and the supernatants were discarded. The remaining solids 
were thoroughly rinsed with anhydrous ethanol and deionized 
water to remove excess docetaxel.
Conjugation of DPM to SWNT-DTX
The SWNT-DTX were resuspended in an aqueous solution of 
PVPk30 10 mg/mL and DPM 0.1 mg/mL,30 and the solution 
was then sonicated using an ultrasonic probe (400 W, 10 times). 
The suspension was then filtered through a membrane filter 
(Whatman, Maidstone, UK) with a pore size of 100 nm 
to remove the excess surfactants, rinsed thoroughly with 
ultrapure H2O, and then centrifuged at 4000 rpm for 15 minutes 
and repeated to remove macromolecular particles.
Preparation of SWNT-NgR-DTX
NGR (CNGRCK2HK3HK11) water solution was added to the 
SWNT-DTX suspension, which was modified by surfactant, 
and DPM with NGR and maleimide in a molar ratio of 1:20.31 
After being left to stand overnight at room temperature, 
SWNT-NGR-DTX was obtained. The solid was washed 
with ultrapure H2O through a membrane filter to remove 
excess NGR.
Thin layer silica gel chromatography using n-butanol-
water-acetic acid (4:2:1) as the developing agent and nin-
hydrin solution 0.5% as the coloring agent were used to test 
for conjugation of NGR to SWNT-DTX.
Characterization of SWNT-NgR-DTX
Determination of loading efficiency of docetaxel
SWNT-NGR-DTX was diluted with acetonitrile and soni-
cated to ensure that the docetaxel was dissolved completely, 
then centrifuged to separate the SWNT and docetaxel to 
determine the amount of docetaxel bound to the SWNT. The 
concentration of docetaxel in acetonitrile was determined by 
high-pressure liquid chromatography. The chromatographic 
conditions were set as follows: an Eclipse XDB-C18 column 
(150 mm × 4.6 mm, 5.0 µm); mobile phase acetonitrile/
water 50:50; column temperature 30°C; detection wave-
length 231 nm; flow rate 1.0 mL/minute; and injection 
volume 20 µL. Absorbance at 808 nm (A808) was used to 
  determine the SWNT concentration in the suspension by 
visible spectrophotometry.29
Determination of size distribution and zeta potential
A 100 µL sample of SWNT-NGR-DTX nanosuspension 
was diluted with ultrapure H2O to 2 mL. The size distribu-
tion and zeta potential of the nanosuspension was deter-
mined at 25°C using a Nano ZS-90 (Malvern Instruments, 
  Worcestershire, UK).
Transmission electron microscopy
The SWNT-NGR-DTX nanosuspension was dripped onto the 
copper line and scanned by transmission electron microscopy 
(Tecnai G2 20) at 100 kV .
Preparation of SWNT-NgR-DTX-FITC 
and cell uptake
Fluorescein isothiocyanate (FITC) 0.1 mL in dimethyl sul-
foxide 1 mg/mL was added to 5 mL of SWNT-NGR-DTX, 
and the mixture was then sonicated and protected from light. 
Gel chromatography was used to remove the excess FITC by 
loading 1 mL of the solution onto a   Sephadex G-25 column 
(Sigma). When the elution solvent (H2O) was flown through 
the column, the formation of two separate yellow bands was 
observed. The fractions were collected, and the absorbance 
of the various fractions was measured at 488 nm with a 
spectrophotometer. Fractions from the first elution peak were 
pooled because they were attributed to the higher molecular 
weight SWNT-NGR-DTX-FITC   conjugate (also confirmed 
by fluorescence measurement).29
PC3 cells were cultured in RPMI medium 1640 supple-
mented with 10% fetal bovine serum and penicillin-strep-
tomycin 1%. The incubations of SWNT-NGR-DTX-FITC 
with PC3 cells were carried out on cover glasses in six-well 
plates, with the cells having been seeded for 24 hours before 
incubation. SWNT-NGR-DTX-FITC was added to each 
well at a final SWNT concentration of 2.5–5 µg/mL. The 
incubations were carried out at 37°C in 5% CO2 for 0.5, 1, 
and 2 hours, respectively. After incubation, the cover glasses 
were washed with phosphate-buffered solution followed by 
soaking for 15 minutes in 4% polymerisatum, then washed 
with deionized water. The cells were imaged by a fluores-
cence microscope (Zeiss LSM 510).
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Cytotoxicity
PC3 cells were plated in 96-well plates and treated with 
different concentrations of SWNT-NGR for 72 hours to 
investigate the cytotoxicity of the delivery system alone, and 
then SWNT-NGR-DTX, SWNT-DTX, or docetaxel for 24, 
48, and 72 hours. The weight ratio of SWNT to docetaxel 
was 1:1.2. Cell viability was measured using the sulforho-
damine B assay.
Pharmacokinetics and biodistribution 
studies
The concentrations of docetaxel in plasma from the tumor-
free healthy mice were measured after intravenous injection 
of SWNT- NGR-DTX, SWNT-DTX, or docetaxel. The dose 
of docetaxel used in this study was chosen to approximate 
the intraperitoneal dosage of docetaxel used in humans 
(75 mg/m2).
The mice were fasted for 12 hours before injection, but 
had access to water ad libitum. The experimental groups 
and the control group were given SWNT-NGR-DTX, 
SWNT-DTX, and docetaxel, respectively (docetaxel in each 
group at 25.125 mg/kg). Blood samples were collected at 
0.083, 0.25, 0.5, 1, 2, and 4 hours after injection. At hours 
0.5, 1, and 2 after administration, the tissues/organs were 
collected, weighed, and homogenized in buffer (acetonitrile to 
saline ratio,1:1) for biodistribution analyses. The weight ratio 
of tissues to buffer was 1:3. The tissues were then sonicated 
to a homogenate. Docetaxel concentrations in plasma were 
analyzed by high-pressure liquid chromatography.
Animal model and treatment
All care and treatment of the animals used in this study was 
performed in accordance with the guidelines for the Care and 
Use of Laboratory Animals published by the National Institutes 
of Health. The S180 tumor models were generated by subcuta-
neous injection of 2 × 106 S180 cells in 0.2 mL of phosphate-
buffered solution into the right shoulder of female BALB/c 
mice. The mice were used for the study when the tumor volume 
reached 100 mm3 (7 days after tumor inoculation).
The animals were divided into five groups (n = 6 per 
group) to receive normal saline (controls), SWNT-NGR, 
docetaxel, SWNT-DTX, or SWNT-NGR-DTX. The injected 
doses were normalized to 25.125 mg/kg of docetaxel. The 
mice were observed daily for clinical symptoms, and the 
tumor sizes were measured by caliper on alternate days, and 
the volume calculated as (tumor width)2 × (tumor length)/2.
The study preparations were injected into the mice via the 
caudal tail vein every 2 days. After seven administrations, 
the mice were euthanized, and tissues from the heart, liver, 
spleen, lung, kidney, brain, thymus, and the tumors were 
harvested and soaked in 10% formalin solution. The   tissues 
collected were embedded in paraffin and mounted on 
slides stained with hematoxylin and eosin. Morphological 
changes were observed under a microscope.
Laser radiation at 808 nm
For the ex vitro laser radiation experiments, SWNT-NGR-DTX 
solutions at high, middle, and low concentrations (SWNT 
approximately 8.3, 4.2, and 0.9 µg/mL; docetaxel about 10, 5, 
and 1 µg/mL) were irradiated by 808 nm laser at 1.4 W/cm2, 
and the temperature was measured.
For the in vitro laser radiation experiments, PC3 were 
seeded in 96-well plates, and incubated with SWNT-NGR-
DTX at high, middle, and low concentrations, respectively. 
Six hours after treatment, the medium containing the drug 
was transferred to fresh medium, and the laser irradiation 
groups were put under an 808 nm laser for 1, 2, and 3 minutes. 
After 24 hours, a sulforhodamine B assay was performed to 
determine cell viability and calculate the inhibition rate.
The in vivo laser radiation experiment followed the same 
steps as for the animal model and treatment section described 
earlier, except that 808 nm laser irradiation was performed 
to tumor tissues in the S180 mice model for one minute after 
each administration.
Statistical analysis
Quantitative data were expressed as the mean ± standard 
deviation. Means were compared using the Student’s t-test 
with SPSS 17.0 statistical software (SPSS Inc, Chicago, IL), 
and P values ,0.05 were considered to be statistically 
significant.
Results and discussion
Preparation of soluble SWNT-DTX
SWNT are not soluble in water, which greatly hinders their 
application as drug carriers. In this study, the dispersion effect 
of several surfactants on SWNT was examined. Lecithin 
High Potency, Poloxamer 188, HS 15, and PVPk30 were 
used at different concentrations. The loading rate was dose-
dependent using PVPk30, and reached a maximum (SWNT 
to docetaxel ratio about 1:1.2) at 10 mg/mL of PVPk30 
(Figure 2).
Because SWNT is a new drug delivery carrier, there is not 
yet a well established method or procedure for its preparation. 
Our experiment adopts the method of saturated solution crys-
talization method, which means that docetaxel is dispersed 
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into a molecular state using a soluble organic solvent, SWNT 
are added, and the water phase is then gradually added under 
ultrasound to reduce the solubility of docetaxel so that it 
can be separated out slowly and attached to SWNT with the 
influence of ultrasonic power. SWNT-DTX is precipitated 
by high-speed centrifugation, the organic solvent and water 
phase are removed, SWNT-DTX is dispersed again into aque-
ous solution with surfactants, and finally the suspension is 
centrifuged to remove the macromolecular particles.
During the preparation process, docetaxel was added 
to the SWNT, but they were difficult to adsorb due to their 
hydrophobic characteristics. Therefore, molecular docetaxel 
was added to make it fully exposed to the surface. When 
the phosphate-buffered water phase was dripped into the 
docetaxel-ethanol solution, docetaxel was gradually precipi-
tated and adsorbed onto the SWNT and, using an ultrasonic 
probe instrument, more energy was applied to achieve 
stronger adsorption. Therefore, the power and frequency 
of the ultrasonic probe had a great impact on drug-loading 
efficiency.
Compared with zwitterionic surfactant, anionic surfactant 
has better dispersion and solubilization effects. However, 
due to its strong hemolytic effect, it cannot be used as an 
additive in injections. In this study, several surfactants for 
injection were chosen. Initially, SWNT were dispersed in 
water, and drugs were then added to the system, but only 
few were adsorbed to SWNT. The reason was probably that 
SWNT were wrapped in the surfactants, which prevented 
the drug from adsorption through π-π stacking interactions. 
We then adopted the nanoprecipitation method to absorb 
the drugs onto the surface of SWNT and then disperse the 
complex with surfactants, which significantly increased the 
drug loading rate.
Preparation of SWNT-NgR-DTX
With maleimide in the DSPE-PEG-maleimide   conjugate, 
which could undergo an addition reaction with the double 
bond in sulfhydryl groups at room temperature, the 
compound reacted with cysteine in CNGRCK2HK3HK11 
(C, containing sulfhydryl groups) and connected covalently. 
Thin layer silica gel chromatography results (Figure 3A) 
showed that there was no free NGR spot after reaction with 
NGR peptides, while there were visible NGR spots when they 
were mechanically mixed with SWNT, which demonstrated 
that NGR had completely attached to the surface of SWNT.
Size distribution is an important parameter for nanoprepa-
ration and hugely affects performance in vivo. As electric 
charges repel each other, potentials on the surface of the par-
ticles can prevent them from flocculation and keep the system 
stable. Charged particle dispersion is measured as the zeta 
potential, which is closely related to physical   stability. 
The SWNT-NGR-DTX particle size was 182.8 ± 2.8 nm 
(Figure 3D) and the zeta potential was −12.06 ± 0.71 mV 
(Figure 3E). It is noteworthy that SWNT-NGR-DTX solution 
can keep a few weeks or even months without aggregation 
(Figure 3C).
SWNT showed a filamentous distribution, and docetaxel 
was attached to the surface of the SWNT (Figure 3B), which 
was reversible. Therefore, when the organism absorbed SWNT, 
docetaxel could be easily dissociated and take effect.
NGR plays the role of angiogenesis-targeting peptide in 
the preparation. If NGR is added before the surfactants, it 
will be adsorbed onto the surface of the SWNT and affect 
targeting effort, as SWNT also have the adsorbing effect 
towards protein. Therefore, SWNT-DTX is prepared first, 
then DSPE-PEG-maleimide is added into it. As in the phos-
pholipids, the DSPE exerts a strong dispersing effect by 
adsorbing one end to SWNT, the long-chain PEG exposes 
maleimide, which induces an addition reaction with NGR, 
and NGR lies at the outer end of the complex, which assures 
its targeting effect.
Cell uptake by SWNT-NgR-DTX-FITC
The SWNT drug delivery system can effectively deliver 
drugs into cells and inhibit phagocytic ability. In this study, 
uptake of FITC, SWNT-DTX-FITC, and SWNT-NGR-
DTX-FITC by PC3 cells was examined. With the properties 
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Figure 2 Effects of different surfactants on loading rate. Concentrations of PVPk30, 
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Figure 3 Characterization of SWNT-NgR-DTX. (A) Thin layer silica gel chromatography image of 1-(NgR), 2-(NgR mechanical mixing with the SWNT-DTX), and 
3-(SWNT-NgR-DTX); (B) transmission electron microscopic image of SWNT-NgR-DTX; (C) solubility of SWNT-NgR-DTX; (D) particle size of SWNT-NgR-DTX; and 
(E) zeta potential of SWNT-NgR-DTX. 
Abbreviations: SWNT, single-walled carbon nanotubes; NgR, (Asn-gly-Arg) peptide; DTX, docetaxel.
of the SWNT surface, it is easy to adsorb the large π bond 
and cause a π-π stacking effect. With multibenzenes in the 
FITC molecular structure, it can easily be adsorbed onto the 
surface of SWNT.
Fluorescence microscopy was applied to track the location 
of docetaxel and the fluorescein-labeled SWNT inside cells 
(Figure 4). As mentioned earlier, the drug delivery experi-
ment is based on the hypothesis that functionalized SWNT 
are taken up by PC3 cells through endocytosis. However, the 
FITC is mainly observed outside the cell. Although drugs can 
enter cells themselves, nanotubes still play an important role 
because they enable molecular targeting via the attachment 
of NGR peptides and are crucial for the delivery of drugs 
that are not taken up by cells under normal conditions. This 
experiment showed that uptake of SWNT-NGR-DTX-FITC 
and SWNT-DTX-FITC by PC3 cells was time-dependent, 
with uptake of all SWNT-NGR-DTX-FITC into PC3 cells at 
2 hours, but only a part of SWNT-DTX-FITC was transferred 
into the cells at this time point (Figure 4). Apart from this, our 
results provide an answer to whether carbon nanotubes enter 
the nuclei of cells. This study clearly shows the nanotubes 
located in the cytoplasm under the applied conditions.
Cell viability
The concentration of docetaxel was 8 µg/mL and for SWNT 
was about 6.7 µg/mL. When the concentration of SWNT 
was below 6.7 µg/mL, the SWNT-NGR had no signifcant 
cytotoxicity to the PC3 cells (Figure 5), but proliferation of 
the PC3 cells was inhibited in the docetaxel, SWNT-DTX, 
and SWNT-NGR-DTX groups, with the inhibition rate being 
positively correlated with dose and time. The correspond-
ing inhibition rates at each time point for the docetaxel and 
SWNT-NGR-DTX groups were significantly different (Fig-
ure 6). However, at the time points of 48 hours and 72 hours, 
as shown in Figure 6, there is no significant difference between 
SWNT-NGR-DTX, SWNT-DTX, and docetaxel. This is 
probably due to the fact that the targeted delivery system 
can be transferred faster into cells, and as a result, its effect 
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  SWNT-DTX and SWNT-NGR-DTX after administration. 
The blood concentration of docetaxel rapidly declined to the 
quantitation limit, while the decreasing rate of SWNT-NGR-
DTX and SWNT-DTX was evidently slower, the decreasing 
rates in the SWNT-DTX and SWNT-NGR-DTX groups were 
not significantly different, but the rates of both were markedly 
different from that of the docetaxel group.
The area under the curve for SWNT-NGR-DTX was 
about six and 64 times greater than for SWNT-DTX and 
docetaxel, respectively, while the elimination rate was less 
(Table 1) and mean residence time was 1.6 and 2.6 times 
longer, respectively (Table 2). This result is attributed to the 
high hydrophobicity of conjugated docetaxel, reducing the 
biological inertness of docetaxel in vivo and shortening 
the blood circulation time. This shows that SWNT-NGR-
DTX significantly increased the blood circulation time of 
docetaxel.
To clarify the tumor treatment efficacy of the various doc-
etaxel formulations (SWNT-NGR-DTX, SWNT-DTX, and 
docetaxel), the biodistribution of docetaxel was investigated 
in tumors and various organs in the mice. For quantitative 
evaluation of the targeting characteristics of SWNT-NGR-
DTX in vivo, several parameters were applied, including 
overall targeting efficiency (TE), ie, the percentage of drug 
distribution in the tissues. The formula, applicable to all 
tissues, is as follows:
  TE
AUCi
AUC
h
h
i
n =×
→
→
= ∑
()
()
%
03
03
1
100
The calculation of AUC0→3h was performed using a trap-
ezoidal method. Significant differences were observed for 
the biodistribution of docetaxel administered in the three 
different formulations (Figure 8B).
The AUC0→3h of docetaxel in SWNT-NGR-DTX for the 
liver, spleen, lung, kidney, and tumor tissue was markedly 
larger than in the docetaxel control group. Compared with 
the SWNT-DTX group, distribution of SWNT-NGR-DTX 
in the liver, spleen, lung, and kidney was reduced, while 
distribution in tumor tissues was significantly increased, 
and little docetaxel reached the tumor tissues when the drug 
was administered alone (Figure 8B). It was demonstrated 
that SWNT functionalized by the PVPk30 method has a 
particular distribution pattern, so eventually the targeting 
efficiency of SWNT-NGR-DTX was similar or even less in 
tumor tissue than in other organs. However, the NGR effect 
can reduce the distribution of SWNT-DTX in other organs, 
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Figure 4 Fluorescence microscopic images of PC3 cells. (A) control group; (B) 
FITC alone; (C) SWNT-DTX-FITC; and (D) SWNT-NgR-DTX-FITC at 0.5, 1, 
and 2 hours. 
Abbreviations:  SWNT,  single-walled  carbon  nanotubes;  NgR,  (Asn-gly-Arg) 
peptide; DTX, docetaxel; FITC, fluorescein isothiocyanate.
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Figure 5 Cytotoxicity of SWNT-NgR in PC3 cells. 
Note: Data are presented as the mean ± standard deviation (n = 3). 
Abbreviations:  SWNT,  single-walled  carbon  nanotubes;  NgR,  (Asn-gly-Arg) 
peptide.
is significantly better than for the other two groups in the 
early stages. However, when the time periods are prolonged 
to 48 hours and 72 hours, the docetaxel in all groups is trans-
ferred into the cells, so the advantage is weakened.
Pharmacokinetics and biodistribution
The pharmacokinetics of docetaxel, SWNT-DTX, and 
SWNT-NGR-DTX were investigated in the blood samples 
by high-pressure liquid chromatography (Figure 7),   showing 
that the rate of decrease of docetaxel was faster than for 
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Abbreviations: SWNT, single-walled carbon nanotubes; NgR, (Asn-gly-Arg) peptide; DTX, docetaxel.
DTX
SWNTs-DTX
SWNTs-DTX-NGR
0
0123
Time (h)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
µ
g
/
m
L
)
45
1
2
3
4
5
6
7
8
9
Figure 7 Mean docetaxel concentration in plasma after intravenous administration of 
docetaxel, SWNT-DTX, and SWNT-NgR-DTX (mean ± standard deviation, n = 5). 
The decreasing rates of SWNT-DTX and SWNT-NGR-DTX were not significantly 
different, but the rate of both were markedly different from that in the docetaxel 
group (P , 0.05). 
Abbreviations:  SWNT,  single-walled  carbon  nanotubes;  NgR,  (Asn-gly-Arg) 
peptide; DTX, docetaxel.
Table  1  The  pharmacokinetic  parameters  of  DTX  after 
intravenous administration of DTX, SWNT-DTX, and SWNT-
NgR-DTX in mice
Parameter Unit SWNT-DTX SWNT-NGR- 
DTX
DTX
V(c) L/kg 0.643 0.547 0.477
t1/2 α h 0.264 0.226 0.123
t1/2 β h 148.948 738.729 12.728
K21 L/h 0.198 0.245 0.357
K10 L/h 0.062 0.012 0.860
K12 L/h 2.367 2.813 4.479
AUC (µg/mL) ⋅ h 125.952 777.614 12.188
CL(s) mL/h/µg 0.0396 0.00643 0.410
Note: All data are the average of five measurements. 
Abbreviations: AUC, area under the curve; CL, clearance; V, volume of distribution; 
t½, elimination half-life; K, elimination rate constant; SWNT, single-walled carbon 
nanotubes; NgR, (Asn-gly-Arg) peptide; DTX, docetaxel; NS, normal saline.
and increase distribution in the tumor to achieve better treat-
ment of cancer.
The targeting efficiency values for SWNT-NGR-DTX 
in the liver and tumor were higher than in the docetaxel 
control group (Figure 8A), indicating good targeting of 
SWNT-NGR-DTX to the liver and tumor tissues. The 
concentration of docetaxel in each tissue was increased by 
SWNT-DTX, which should enhance the therapeutic effect 
to a certain extent.
Laser radiation
In this study, three different concentrations of SWNT-
NGR-DTX were irradiated under laser, and temperature 
changes with time were measured. The heating efficiency of 
  SWNT-NGR-DTX relies strongly on time and dose, meaning 
that with increasing concentration and time, the temperature 
was significantly higher (Figure 9). Under laser irradiation 
at 808 nm, SWNT-NGR-DTX showed strong light-heat 
transfer characteristics.
The inhibition rate of the SWNT-NGR-DTX complex 
towards PC3 cells was significantly increased under 808 nm 
near-infrared laser radiation (Figure 10). When the concen-
tration of SWNT was 14.4 µg/mL, the rate of inhibition 
reached 95.33% after radiation for one minute. When the 
SWNT-NGR-DTX complex containing SWNT 7.3 µg/mL 
was irradiated for one minute, the inhibition rate was about 
35%, but reduced to 90.73% if irradiated for two minutes. 
This is probably due to the fact that cell tolerance drops dra-
matically at a certain temperature during heat treatment, as 
it does for SWNT of different concentrations over   different 
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Table  2  Pharmacokinetic  parameters  calculated  by  statistical 
moment for mice treated with intravenous DTX, SWNT-DTX, 
and SWNT-NgR-DTX
Parameters Unit SWNT- 
DTX
SWNT-NGR- 
DTX
DTX
AUC (S0) (µg/mL) . h 9.888 14.628 7.470
AUMC (S1) (µg/mL) . h 58.802 144.793 28.274
AUMC (S2) (µg/mL) . h 886.286 3426.139 187.986
MRT h 5.947 9.898 3.785
VRT h . h 54.268 136.238 10.893
Abbreviations: AUC, area under the curve; AUMC, area under the first moment 
of the plasma concentration-time curve; MRT: mean retention time; VRT, variance 
of residence time; SWNT, single-walled carbon nanotubes; NgR, (Asn-gly-Arg) 
peptide; DTX, docetaxel.
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Figure 8 Targeting efficiency (A) and AUC0→3 h of DTX concentration (B) in tissues of 
mice after intravenous administration of DTX, SWNT-DTX, and SWNT-NgR-DTX. 
Note: Data are presented as the mean ± standard deviation, (n = 6). 
Abbreviations:  SWNT,  single-walled  carbon  nanotubes;  NgR,  (Asn-gly-Arg) 
peptide; DTX, docetaxel; AUC, area under the concentration versus time curve.
time periods, resulting in an increased inhibition rate for 
SWNT-NGR-DTX from one minute to 2 minutes. The results 
show that SWNT has a significant photothermal effect, and 
when combined with chemotherapy, ideal antitumor effects 
could be reached.
Changes in tumor volume in the S180 mouse model are 
shown in Figure 11A. Compared with the normal saline 
group, the tumor volume in the docetaxel, SWNT-DTX, and 
SWNT-NGR-DTX groups showed a decrease one week after 
administration, but there were some remarkable differences. 
Efficacy in the SWNT-NGR-DTX and SWNT-DTX groups 
was superior to that in the docetaxel group, and both were 
markedly different from the docetaxel group. However, no 
significant variation was observed between the SWNT and 
normal saline groups.
In vivo, the results of the laser irradiation experi-
ment (Figure 11B) showed that tumor volumes in the 
normal saline-laser and docetaxel-laser groups were both 
decreased when compared with the normal saline and 
docetaxel groups, respectively. There was a significant dif-
ference, indicating that radiation had an antitumor effect. 
The   statistical results indicated a marked difference and 
better outcome in the SWNT-NGR-laser group than in 
the normal saline, normal saline-laser, and SWNT-NGR 
groups. The SWNT-NGR-DTX-laser group showed the 
best antitumor results and a strong inhibitory effect, even 
in the early stage of treatment. The results confirmed that 
radiation at 808 nm can significantly enhance the tumor 
inhibition effect.
In recent years, photothermal therapy based on nanoma-
terials has been suggested as a highly efficient therapeutic 
technique. Moon et al used PL-PEG2000-NH2 to functional-
ize SWNT, and demonstrated that the photothermal effect of 
PEG-SWNT exposed to near-infrared irradiation can destroy 
solid malignant tumors in vivo. SWNT-based photothermal 
treatment achieved complete eradication of solid malignant 
tumors without toxicity or recurrence of tumors for a long 
period of time.27 Using PEG-PMHC18-coated SWNT, Liu 
et al carried out a pilot in vivo photothermal therapy study 
and observed promising efficacy in cancer cells. Their results 
highlight the importance of surface coating for the in vivo 
behavior of nanomaterials in general, and could provide 
guidelines for the future design of SWNT bioconjugates for 
various in vivo applications.25 Yang et al used nanographene 
sheets with polyethylene glycol (PEG) coating to exploit 
the strong optical absorbance of nanographene sheets in 
the near-infrared region for in vivo photothermal therapy, 
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achieving ultraefficient tumor ablation after intravenous 
administration of nanographene sheets and low-power near-
infrared laser irradiation to the tumor.32 SWNT functionalized 
by PEGylated phospholipids are biologically nontoxic and 
long-circulating nanomaterials with intrinsic near-infrared 
photoluminescence.28 All the studies shared the same feature 
of modifying SWNT with PEG. Our study adopts the method 
of surfactant modification, whereby DPM is used at a low 
dose to conjugate with NGR, and the effect of using heat 
with this method is still significant.
Histological analysis
To investigate the influence of SWNT-NGR-DTX on the 
organs of mice, a histological assay was conducted with 
paraffin-embedded sections and hematoxylin and eosin 
staining (Figure 12) which showed that, compared with the 
control group, there were no significant differences between 
the various tissues. However, tumor cells in the control group 
showed vigorous growth, a tight arrangement, a large body 
and intact shape, while cell necrosis, lysis, and fragmentation 
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Figure 12 Histologic assessments of major organs and tumor tissues with hematoxylin and eosin staining in mice (200×). (A) NS, (B) SWNT, (C) SWNT-DTX, (D) DTX, 
(E) SWNT-NgR-DTX, and (F) SWNT-NgR-DTX-laser. 
Abbreviations: SWNT, single-walled carbon nanotubes; NgR, (Asn-gly-Arg) peptide; DTX, docetaxel; NS, normal saline.
occurred to a certain extent in the docetaxel, SWNT-DTX, 
SWNT-NGR-DTX, and SWNT-NGR-DTX-laser groups. No 
significant morphological difference was found between the 
SWNT group and the control group.
Conclusion
In summary, a new anticancer drug delivery system using 
docetaxel as a model, ie, SWNT-NGR-DTX, was developed 
to identify the biodistribution characteristics of SWNT and 
their effect on cancer cells when mediated by thermal therapy. 
The targeting efficiency of SWNT-NGR-DTX in tumor tissue 
was enhanced compared with SWNT-DTX and docetaxel. 
It is suggested that this SWNT drug delivery system may be 
promising in terms of treatment efficacy for cancer and with 
minimal side effects.
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